Prostate News and Research

RSS

Unified and concentrated lung cancer advocacy program results in 25% increase in research funding

A unified and concentrated lung cancer advocacy program in the United States resulted in a 25 percent increase in funding to a U.S.-based lung cancer research program, according to a presentation given today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.

12 Sep 2023

Effective treatment for lower urinary tract symptoms linked to lower mortality risk in older men

Effective treatment for lower urinary tract symptoms (LUTS) in men aged 50 or older is associated with a lower risk of death over the next few years reports a study in the October issue of The Journal of Urology, an Official Journal of the American Urological Association.

11 Sep 2023

PI3K pathway rewiring drives prostate cancer growth

Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators.

11 Sep 2023

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

11 Sep 2023

Is there an association between the COVID-19 pandemic and cancer incidence?

The COVID-19 pandemic influenced cancer incidence.

8 Sep 2023

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

An international study published in BMJ Oncology analyzes the Global Burden of Disease 2019 dataset to explore the rising incidence and mortality rates of early-onset cancers (ages 14-49) worldwide. The study highlights varying cancer burdens by gender and region, identifies lifestyle and environmental risk factors, and predicts a significant increase in early-onset cancer rates by 2030.

7 Sep 2023

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

The COVID-19 pandemic led to a notable decline in new cancer diagnoses in Manitoba, Canada, particularly affecting breast, colon, and rectal cancers. The study highlights the urgent need for healthcare strategies to mitigate the impact of future disruptions on cancer detection and treatment.

6 Sep 2023

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy.

5 Sep 2023

Free online tool could potentially mitigate financial toxicity for some prostate cancer patients

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a new study finds.

5 Sep 2023

Early onset cancers exacting heaviest toll on young adults over the past three decades

There's been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990-2019), finds research published today in the open access journal BMJ Oncology.

5 Sep 2023

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

4 Sep 2023

Men with sneaky testosterone physiology have worse prostate cancer outcomes, study finds

First-of-its-kind study on 266 men found 20% have higher levels of the hormone in the vessels surrounding the prostate.

4 Sep 2023

Exposures to biological sources linked to increased risk of chemical intolerance

What initiates chemical intolerance (CI)? In a newly released survey of thousands of U.S. adults, respondents most frequently cited exposures to biological sources, such as mold and algae "blooms," and/or fossil fuels, their combustion products and synthetic chemical derivatives such as pesticides, plastics and persistent organic pollutants.

1 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

KFF Health News' 'What The Health?': 3 health policy experts you should know

In this special episode, host Julie Rovner, KFF Health News' chief Washington correspondent, interviews three noted health policy experts.

31 Aug 2023

The Clinical Importance of Circulating Tumor DNA

Cancer remains a leading killer among medical causes of death worldwide.

31 Aug 2023

Researchers unearth secrets of zinc transporter protein

A group of researchers has unearthed the secrets behind a tiny but crucial protein that shuttles zinc ions (Zn2+) within our bodies. The discovery offers a deeper understanding of how our cells maintain optimal health.

31 Aug 2023

Exercise may help improve sexual function in prostate cancer patients

Prostate cancer is one of the most common forms of cancer in the world, but not only does it put the lives of those diagnosed at risk, but can also severely impact patient quality of life due to side-effects of treatment.

30 Aug 2023

AI chatbot provides incorrect cancer treatment recommendations

Researchers evaluate the reliability of large language models (LLMs) in providing cancer treatment recommendations, finding that 33.33% of the chatbot's advice was partially non-concordant with established guidelines. The study highlights the need for caution and regulation as AI technologies infiltrate healthcare decision-making.

29 Aug 2023

Study challenges the use of biochemical recurrence as prostate cancer predictor

A UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient's long-term overall survival.

28 Aug 2023

Prostate News and Research

Unified and concentrated lung cancer advocacy program results in 25% increase in research funding

Effective treatment for lower urinary tract symptoms linked to lower mortality risk in older men

PI3K pathway rewiring drives prostate cancer growth

Exploring the anti-cancer potential of dark tea

Is there an association between the COVID-19 pandemic and cancer incidence?

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

Free online tool could potentially mitigate financial toxicity for some prostate cancer patients

Early onset cancers exacting heaviest toll on young adults over the past three decades

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

Men with sneaky testosterone physiology have worse prostate cancer outcomes, study finds

Exposures to biological sources linked to increased risk of chemical intolerance

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

KFF Health News' 'What The Health?': 3 health policy experts you should know

The Clinical Importance of Circulating Tumor DNA

Researchers unearth secrets of zinc transporter protein

Exercise may help improve sexual function in prostate cancer patients

AI chatbot provides incorrect cancer treatment recommendations

Study challenges the use of biochemical recurrence as prostate cancer predictor

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News